Innate Pharma
IPHA
#8439
Rank
A$0.21 B
Marketcap
$2.62
Share price
1.19%
Change (1 day)
-29.41%
Change (1 year)

Innate Pharma (IPHA) - Cash on Hand

Cash on Hand as of December 2023 : A$0.15 Billion

According to Innate Pharma 's latest financial reports the company has A$0.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Innate Pharma - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.15 B-14.54%
2021-12-31A$0.18 B-22.82%
2020-12-31A$0.24 B-30.73%
2019-12-31A$0.35 B28.72%
2018-12-31A$0.27 B52.45%
2017-12-31A$0.17 B-38.14%
2016-12-31A$0.28 B-18.53%
2015-12-31A$0.35 B244.12%
2014-12-31A$0.10 B60.72%
2013-12-31A$64.01 M54.2%
2012-12-31A$41.51 M-29.67%
2011-12-31A$59.02 M30.36%
2010-12-31A$45.28 M-42.28%
2009-12-31A$78.45 M17.04%
2008-12-31A$67.03 M-20.96%
2007-12-31A$84.81 M-15.3%
2006-12-31A$0.10 B237.21%
2005-12-31A$29.69 M